Zhang Yu, Ren Ting, Li Hongyu, Zhu Luwen, Tang Qiang
Department of Rehabilitation, Heilongjiang University of Chinese Medicine, Harbin, China.
Department of Rehabilitation, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Medicine (Baltimore). 2020 Sep 18;99(38):e22177. doi: 10.1097/MD.0000000000022177.
Anxiety disorder places a heavy burden in the clinical treatment of patients of COVID-19. Acupuncture is a recommended treatment of COVID-19 in China, and clinical researches showed the effectiveness of acupuncture. We will conduct this systematic review and meta-analysis to assess the effectiveness and safety of acupuncture for COVID-19.
Electronic databases of Medline, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI), Chinese Biomedical literature Database (CBM), Chinese Scientific and Journal Database (VIP), and Wan Fang database (Wanfang) will be searched for randomized controlled trials of acupuncture for anxiety disorder of COVID-19 from inception of the database to August 10, 2020. Two reviewers will screen studies, collect information independently. We will utilize RevMan 5.3 for meta-analysis.
We will publish the study result to a peer-reviewed journal.
This study will contribute to provide high-quality evidence of acupuncture for anxiety disorder of COVID-19.
焦虑症给新型冠状病毒肺炎患者的临床治疗带来沉重负担。针灸是中国推荐的新型冠状病毒肺炎治疗方法，临床研究表明了针灸的有效性。我们将进行这项系统评价和荟萃分析，以评估针灸治疗新型冠状病毒肺炎的有效性和安全性。
将检索Medline、EMBASE、Cochrane图书馆、中国知网（CNKI）、中国生物医学文献数据库（CBM）、中文科技期刊数据库（VIP）和万方数据库（Wanfang）等电子数据库，以查找从数据库建立至2020年8月10日期间关于针灸治疗新型冠状病毒肺炎焦虑症的随机对照试验。两名评价员将筛选研究、独立收集信息。我们将使用RevMan 5.3进行荟萃分析。
我们将把研究结果发表在同行评审期刊上。
本研究将有助于为针灸治疗新型冠状病毒肺炎焦虑症提供高质量证据。
